Literature DB >> 14572149

Recovery from mild head injury in pediatric populations.

Matthew D Thompson1, James W Irby.   

Abstract

This article provides an overview of the diagnosis, classification, and pathophysiology of mild head injury (MHI) in children. The difficulties associated with determination of MHI severity are outlined. Also, recently published research pertaining to pediatric MHI is reviewed. The recent research pertaining to MHI in children is generally consistent with the conclusions reached by the authors of the most recent comprehensive review, which reported that children who have suffered MHI often experience a symptomatic phase that could extend up to a few months, but these symptoms usually resolve. Numerous preinjury variables have been identified, including premorbid learning and behavior problems, disadvantaged socioeconomic status, premorbid neurodevelopmental abnormalities, and adverse family conditions, that appear to explain the persistence of some symptoms experienced by a subset of children with MHI. Directions for future research are provided.

Entities:  

Mesh:

Year:  2003        PMID: 14572149     DOI: 10.1016/s1071-9091(03)00021-4

Source DB:  PubMed          Journal:  Semin Pediatr Neurol        ISSN: 1071-9091            Impact factor:   1.636


  3 in total

Review 1.  Whole-brain N-acetylaspartate: a marker of the severity of mild head trauma.

Authors:  Mauricio Castillo
Journal:  AJNR Am J Neuroradiol       Date:  2007-05       Impact factor: 3.825

2.  Kinematic Comparison of Pediatric Human Volunteers and the Hybrid III 6-Year-Old Anthropomorphic Test Device.

Authors:  Thomas Seacrist; Sriram Balasubramanian; J Felipe García-España; Matthew R Maltese; Kristy B Arbogast; Francisco J Lopez-Valdes; Richard W Kent; Hiromasa Tanji; Kazuo Higuchi
Journal:  Ann Adv Automot Med       Date:  2010

Review 3.  Post-concussive Signs and Symptoms in Preschool Children: A Systematic Review.

Authors:  Joy Noelle Yumul; Louise Crowe; Cathy Catroppa; Vicki Anderson; Audrey McKinlay
Journal:  Neuropsychol Rev       Date:  2021-08-14       Impact factor: 6.940

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.